Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

  • June 2025 quarter CPI no roadblock to August RBA rate cut
    June 2025 quarter CPI no roadblock to August RBA rate cut
    • News

  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    • News

  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    • News

  • Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    • News

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    • News

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

Keypath Education’s healthcare focus in the US and APAC boosts EBITDA

  • In News
  • October 31, 2023
  • Alinda Gupta
Keypath Education’s healthcare focus in the US and APAC boosts EBITDA

The global healthcare workforce is set to experience a squeeze, as the WHO estimates 10 million fewer workers by 2030. Lack of funding, disproportionate migration and low wages are just some of the reasons. This is a worrying picture, especially following the Covid-19 pandemic. 

One company working towards remedying this is the global EdTech provider Keypath Education (ASX: KED), which develops online higher education programs across Australia, the United States, Canada, the UK, Malaysia and Singapore. The Company has been expanding its Healthcare programs, including Nursing, Speech Pathology, and Mental Health.

Following its FY23 results, Keypath Education shifted its focus to the Healthcare segment, seeing it was driving program demand in light of overall dwindling enrollments. 

In Q1 FY24, it saw a revenue of $55.76 million, 13.1% higher than Q1 FY23. Its revenue within the Healthcare segment represented a 27.8% rise. Its Q1 FY24 adjusted EBITDA of $3.5 million was $8.8 million higher than Q1 FY23.

Keypath’s Founder and CEO, Steve Fireng, said, “We are pleased with our progress in FY24 with strong revenue and adjusted EBITDA growth in Q1 FY24 keeping us on track to meet our FY24 guidance. These Q1 FY24 results show the progress we are making in our strategic focus on Healthcare in the US and the APAC region, providing us with confidence in driving revenue growth and continued profitability improvements in the coming periods, including achieving breakeven adjusted EBITDA from H2 FY24.”

Keypath expects that its future vintages (where vintage is the year when the programs welcome their first students) will achieve $39.3 million to $54.9 million in revenue at maturity. With online education services still thriving after the pandemic, Keypath is well-positioned to serve a range of segments. 

Overall, it saw its course enrollments increase by 6.6% on Q1 FY23 to 36.7k students. It is witnessing strong demand for programs in the North American region for Healthcare and, more broadly, in APAC.

Keypath saw an increase in the contribution margin, or profitability of its services, by $6.9 million, reaching $16.6 million. This increase was attributed to large recent vintages progressing to maturity, offsetting the large number of programs it has recently signed, which are in their deepest investment phase. 

Its operating cash outflow was $18.8 million, reflecting the timing of collections and payments and employee and direct marketing costs. Q1 and Q3 are typically lower cash receipt quarters for Keypath as its largest student enrollments generally are in these quarters with a relatively high cash outflow versus inflow. The timing of launches and spending on new programs also impacts quarterly cash flow. 

In FY24, the Company will keep investing in newer vintages. It reaffirmed its guidance for FY24 of revenue between $204.2 million and $212.06 million. It is also targeting adjusted EBITDA profitability from H2 FY24.

As of September 30, 2023, the Company had cash on hand of $51.7 million.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • asx ked
  • EdTech
  • Keypath Education
  • steve fireng
  • World Health Organisation
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.